Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Valion Bio (TIVC) Asset Utilization Ratio (2022 - 2025)

Valion Bio has reported Asset Utilization Ratio over the past 4 years, most recently at 0.09 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 61.64% year-over-year to 0.09; the TTM value through Sep 2025 reached 0.09, down 61.64%, while the annual FY2024 figure was 0.2, 8.12% down from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.09 at Valion Bio, down from 0.11 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.28 in Q2 2024 and troughed at 0.09 in Q3 2025.
  • A 4-year average of 0.2 and a median of 0.21 in 2023 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 180.7% in 2023 and later crashed 61.64% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.26 in 2022, then fell by 26.04% to 0.19 in 2023, then soared by 30.11% to 0.25 in 2024, then crashed by 64.31% to 0.09 in 2025.
  • Business Quant data shows Asset Utilization Ratio for TIVC at 0.09 in Q3 2025, 0.11 in Q2 2025, and 0.16 in Q1 2025.